Getting latest data loading
Home / Morning Report / Morning Report – 27th April 2026

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 27 April 2026

Yesterday’s UK 100 Leaders Price (p) % Chg
British American Tobacco 4,302.0 2.3%
InterContinental Hotels Group 146.0 2.2%
London Stock Exchange Group 9,992.0 1.8%
Sage Group 902.8 1.6%
Marks & Spencer Group 347.0 1.6%

 

Yesterday’s UK 100 Laggards Price (p) % Chg
Mondi 748.2 -11.1%
Babcock International Group 1,131.5 -4.6%
Antofagasta 3,686.0 -3.8%
AstraZeneca 13,956.0 -3.7%
JD Sports Fashion 69.9 -2.9%

 

Major World Indices Price % Chg 1 Year
UK 100 INDEX 10,379 0.8% 23.3%
DOW JONES INDUS. AVG 49,231 0.2% 22.7%
DAX INDEX 24,129 0.1% 8.5%
NIKKEI 225 59,716 1.0% 67.3%
S&P/ASX 200 INDEX 8,787 0.1% 10.3%

 

Commodity Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 94.40 1.51%
Brent Crude (ICE) USD/bbl. 105.33 0.25%
Gold Spot USD/t oz. 4,710 0.3%
Copper (Comex) USd/lb. 609 0.9%

 

The UK 100 is called to open +11 points at at 10,390.

4 Hours; 4 Months

Click graph to enlarge

Markets Overview:


The UK 100 is called to open +11 points at at 10,390. 
The UK 100 is seen opening flat to marginally higher after Friday’s 0.8% decline.  The domestic macro focus is Thursday’s Bank of England decision. Markets are pricing hikes later this year, but consensus still expects Bank Rate unchanged this week at 3.75%.

The S&P and Nasdaq Composite closed at record levels on Friday.  The broad market index finished up 0.8% at 7,165.08, while the tech-heavy Nasdaq added 1.63% to settle at 24,836.60. Both indexes also scored fresh all-time intraday highs. However, the Dow Jones fell 79.61 points, or 0.16%, to end the at 49,230.71.

Asian indexes traded mostly higher on Monday, and Tokyo’s Nikkei 225 index hit a fresh record Monday after U.S. stocks ended last week with new highs.

Japan gained 1.8% setting new all-time highs as investors largely brushed off diplomatic setbacks between the US and Iran that pushed oil prices higher. Japan’s 10-year government bond yield rose to around 2.45% on Monday, moving closer to levels not seen in nearly three decades as investors positioned for the upcoming Bank of Japan policy decision. The Japanese yen held steady around 159.3 per dollar on Monday after weakening last week.

China’s Shanghai composite rose 0.15%. The offshore yuan edged higher to around 6.82 per dollar, remaining near its strongest level since February 2023. China’s industrial profits surged 15.5% year on year in Q1 2026, accelerating from a 15.2% gain in the first two months of the year.

Hong Kong’s Hang Seng rose 0.15% as early volatility gave way to cautious sentiment amid rising geopolitical tensions and disruptions in energy markets.

Stocks in Australia fell -0.08%. Australia’s 10-year government bond yield traded around 5%, stuck in a sideways range near multi-decade highs as investors continued to grapple with inflation risks linked to the Middle East war. The Australian dollar rose above $0.71, recovering from a roughly 0.3% loss in the previous week.

In other parts of Asia, Taiwan’s consumer confidence index edged up to 62.47 in April 2026 from March’s more than three-year low of 62.3, pointing to only a modest improvement in sentiment.

 

Company News & Broker Comments:

 

Company News:

 

GSK subsidiary, TESARO, Inc., confirmed this morning that the Delaware Chancery Court has granted the motion to dismiss filed by AnaptysBio, Inc. against TESARO’s claim for anticipatory breach. The court’s ruling does not address the merits of the principal contractual dispute between the parties and has no impact on TESARO’s remaining claim against AnaptysBio for declaratory judgment. GSK and TESARO are firmly of the view that these allegations are entirely without merit and remain focused on pursuing that claim at trial.  TESARO initiated this litigation following allegations made by AnaptysBio that TESARO has not fulfilled certain requirements of the license agreement entered in March 2014 between the parties and that AnaptysBio intends to revoke TESARO’s licence for dostarlimab.

 

 

Reporting Today:

 

UK

None

 

US

Verizon Communications (NYSE:VZ) PMO

 

 

Reporting Tomorrow:

 

UK

Card Factory (CARD) – Preliminary Results

Howden Joinery Group (HWDN) – Trading Update

Barclays (BARC) – Q1 2026 Results

BP (BP.) – Q1 2026 Results

 

US

Coca-Cola (KO) PMO

General Motors (GM) PMO

Spotify (SPOT) PMO

Booking Holdings (BKNG) AMC

Mondelez International (MDLZ) AMC

Robinhood Markets (HOOD) AMC

Starbucks (SBUX) AMC

Visa (V) AMC

 

 

In Focus Today:

 

ECB’s Schnabel speech

 

 

This Week’s Ex-Dividends:

 

UK 100 companies going ex-dividend on 30th April 2026:

Weir Group

IG Group Holdings

 

UK 250 companies going ex-dividend on 30th April 2026:

Senior

International Workplace Group

Greggs

Elementis

Genuit Group

4imprint Group

Bodycote

Alfa Financial Software Holdings

 

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.